SEBI has restrained Hemant Ghai and his wife Jaya Hemant Ghai and mother Shyam Mohini Ghai from buying, selling or dealing in securities, either directly or indirectly, in any manner whatsoever till further directions

An investigation was conducted by Sebi into the shares of HPC Biosciences Ltd regarding alleged manipulation in the Initial Public Offer (IPO) process of the company

A Supreme Court said the direction of substituting the fine, which has been imposed for indulging in fraudulent and unfair trading practices, with a warning is contrary to the statutory provision

The regulator said its probe began after receipt of complaints, in 2017 from Quantum Securities Pvt Ltd-- a shareholder of NDTV-- about an alleged violation of rules by non-disclosure of material information to the shareholders about loan agreements with VCPL

\"Noticee 1 to 13 by trading amongst themselves have manipulated the price of JDL in violation of PFUTP norms,\" the Securities and Exchange Board of India (Sebi) said in its 55-page order on Thursday

Sebi had initiated investigation into trading of shares of GSL after receiving reference from the Income Tax Department. It was found that Global Securities Ltd (GSL) had in October 2010 come out with preferential allotment which turned out to be a sham

As per the annual accounts of Sebi, the total expenditure of the regulator also rose to Rs 492.34 crore for the year ended March 31, 2019, from Rs 414.46 crore in the previous fiscal

The trading pattern adopted by the entities together clearly demonstrates their ill-intentioned design to inflate the price of the scrip through artificial and manipulative trades, SEBI said

Sebi said that AstraZeneca Pharma India Ltd's promoter AstraZeneca Pharmaceuticals AB Sweden (AZPAB), and Elliott Group, which held 15.52% stake in the company, had a 'private arrangement' to sail through the delisting process

During the probe, it was found that these entities were connected and indulged in manipulating the price of the scrip downwards through a complex web of accumulating and distributing shares in the off-market

The company and its directors had mobilised funds to the tune of over Rs 2,686 crore by running unregistered collective investment schemes between 2013 and 2014

Share price of Morepen Laboratories fell over 17% intraday on Wednesday, after market regulator barred Morepen Laboratories from the capital market for one year for making misleading disclosure about the issuance of global depository receipts (GDRs).

India's National Stock Exchange (NSE) won a partial reprieve on a $90 million regulatory fine for allegedly giving unfair access to its network servers, as an appellate tribunal on Wednesday announced an interim hold on the penalty.